Nakayama, T <br/><br/>
Beneficial effects of TDN-345, a novel Ca2+ antagonist, on ischemic brain injury and cerebral glucose metabolism in experimental animal models with cerebrovascular lesions.  [electronic resource] 

 -  Brain research  Jul 1997 
 - 203-10 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0006-8993 
<br/><br/><label>Standard No.: </label>10.1016/s0006-8993(97)00388-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain--blood supply<br/>Brain Ischemia--drug therapy<br/>Calcium Channel Blockers--pharmacology<br/>Cerebrovascular Disorders--drug therapy<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Gerbillinae<br/>Glucose--metabolism<br/>Male<br/>Neuroprotective Agents--pharmacology<br/>Rats<br/>Rats, Inbred SHR<br/>Rats, Inbred WKY<br/>Reperfusion Injury--drug therapy<br/>Spiro Compounds--chemistry